Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease

Patients who have kidney disease receive aspirin, β blockers, lipid-lowering therapy, thrombolytic agents, and coronary interventions less often than patients who have normal kidney function. The odds of dying during hospitalization for acute myocardial infarction were significantly higher among patients who had kidney disease than among those who did not have kidney disease after adjusting for several demographic and clinical confounders and year of hospitalization.